CRT Pioneer Fund invests in BCL6 project
The Cancer Research Technology Pioneer Fund is making its ninth investment in a project aiming to develop a new class of therapies for patients with diffuse large B-cell lymphoma – a sub-type of Non-Hodgkin Lymphoma (NHL).
Read More
